Can a smartphone app teach resilience to young cancer patients?

NCT ID NCT05842902

Recruiting now Symptom relief Sponsor: Seattle Children's Hospital Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This pilot trial tests whether a mobile app version of a resilience-building program, called mPRISM, is acceptable and helpful for adolescents and young adults recently diagnosed with cancer. The app teaches coping skills like stress management, goal-setting, and reframing negative thoughts. Researchers will measure how usable and feasible the app is, and whether it improves quality of life and mental health symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mPRISM, a mobile app version of the PRISM resilience skills program
What this could lead to: If the app proves helpful, it could offer a convenient way to support emotional well-being and coping skills for young cancer patients.
What could go wrong: This is a small pilot study, so results may not apply broadly. The app's benefits are uncertain, and not all participants may find it easy or useful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Seattle Children's Hospital
RECRUITING

Seattle, Washington, 98105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.